{"ticker": {"uuid": "aef8a652-c227-4ef6-bc85-7db8a9fa4610", "symbol": "CRDL", "name": "Cardiol Therapeutics Inc.", "exchange": "TOR", "country": "CA", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Cardiol Therapeutics Inc (CRDL) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE5pUWNuWENHNTZSbVdRNGhLS2JGcXdwbm5GQ2JobUFnNElDRDMyTEo4VGJmYkRzREcwQmd0ZGFpTDFsTTdKX1pJSF9TWFpOZEs4UDhHLVI0blpTdElOc19uQ3lZUUhBSzhOdVRBc0czSkQ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-19T03:20:32+00:00", "published_display": "19 Jun 2026 03:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Inc (CRDL) Institutional Confidence", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTFBVTnNDZ283ajdVMDczV1Y1N0syVnNwSTZHYy1MWGJsRkotS01JMjZWZUplOHdLWXlFeDJNUXlkUzQ2MkNNZEttbHNtNk0yM1l6Q25hTEVoc1lmSW1FRm1jNEpCWFhGRzdrVExvZjdjVGY?oc=5", "source_name": "TradingKey", "published_at": "2026-06-19T02:43:36+00:00", "published_display": "19 Jun 2026 02:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Inc (CRDL) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE9SeUNWb3JHTWZ3T3ctemN4LUFBdnh2RUpnM1FyaGN5YTVBNTcxSUxpTDNFRlF2dVA3cjBERmxveV9acDBtSWVsUnVKLW1vczVTQ2l2UWZGbUViYWxvcVZFYlNidEFzU21YeW9XbWltYlRzWXlNVXZR?oc=5", "source_name": "TradingKey", "published_at": "2026-06-19T02:41:30+00:00", "published_display": "19 Jun 2026 02:41", "sentiment": "negative", "sentiment_pct": 5, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Inc (CRDL) Financial Health: Profitability & Balance Sheet Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTFB4QlEwRzF6WlJua0VEdW9RYWtabXRUNEZVZWNFenRqYmVLdC1oQk5xNG8tMlJIMEtnMTM5WUY1V0NtUkotR05Rclo4M3ljd2VkTDBmZDRQaTQxQ211N0lrbTc0SEpZMGVkbXozQzBDbzRsMXYtb24wa1lR?oc=5", "source_name": "TradingKey", "published_at": "2026-06-19T02:13:47+00:00", "published_display": "19 Jun 2026 02:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CRDL News | CARDIOL THERAPEUTICS INC-A (NASDAQ:CRDL)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTFBQbzZOVkRLVk1yUUlFLTgtYkFJYUp0eng4bDc5M29fMDhSUjU0bWNMZk9vZGEtcGQxVE1neThHQjVsVWI3N2wzRjFBWkQtdlYza3hGeXlEb09YSzA?oc=5", "source_name": "ChartMill", "published_at": "2026-06-19T00:00:01+00:00", "published_display": "19 Jun 2026 00:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Inc (CRDL) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTE1CUkwyN2ljQ29LSVRfV0Q5TnozcjhIbDdCS1pHVkpxY19Wbmp4NXlDRzltZ3MwM3ZYOERtM3Y4Ymp6S1ZSQnJiZjd4WjFmZHR0WnZxbkVLYnB0UERuSFZhQkRXbEUycnFXU05tUUotSQ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T23:39:30+00:00", "published_display": "18 Jun 2026 23:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Inc (CRDL) Valuation: PE, PB & Fair Value Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE1RMDNfVDJxMjZsek96NFhyR0NGb1Z0bklxbXhzVTZqOTJIbW94Q1N3bkJDcWdNbGFPVi1PVXExRkY1NE5SWHAtYzVLR1dKQ25oRkhQOWVJMHJYZ0NSVVNFWk43a2J3QjRuVDdxcjZHQ3U2NENPXzRfVjVTWQ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T23:34:21+00:00", "published_display": "18 Jun 2026 23:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Inc (CRDL) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE5Mc1lWTlc0SlczaUpoTjRyM0dQYVBjNWpaNWtMSU51Z3FxWmhxd0xjZmZGanhDM05pS1BRQ05QSE53M05aYTI3anc4Zl85Wk16QlpDWXZZdEdBeF9qblV2UjlZXzNZLVpVRlZZZmZYWFA?oc=5", "source_name": "TradingKey", "published_at": "2026-06-17T21:31:22+00:00", "published_display": "17 Jun 2026 21:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Inc (CRDL) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE9jUUk1dU0tczIwaC1DT2FjVHhHemNYNWZDU3RwR0FFR0VDd3RoemN4RDNGdFBPMVZRV252V0pDYlV1bjQtaWNYNk1DcTBGdUVxcmZ0cjZLTlVqZ3hBUk1MUzllU1dYVXlBMzRBRmstQ1NYZzRxcVdKUA?oc=5", "source_name": "TradingKey", "published_at": "2026-06-17T12:13:09+00:00", "published_display": "17 Jun 2026 12:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Inc (CRDL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTFBoM1dXeGxCbW5mNm9meXo5aEhKaUN2ZXBwZzhaVkVwaWhTU1E3NHhOSFJTNzBROGxFbDNSNUUwTjlSckRLWG1HVWdnQ291NUZxd3MtSnY5YWdscjcxRm4zX19LNXlFX3drRlJNZjNR?oc=5", "source_name": "TradingKey", "published_at": "2026-06-17T11:22:24+00:00", "published_display": "17 Jun 2026 11:22", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Cardiol Therapeutics (TSE:CRDL) In A Good Position To Invest In Growth?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why We're Watching Cardiol Therapeutics' (TSE:CRDL) Cash Burn Situation", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQcFVTZHF1Ty1SYkxkVGE0dm5qM0Z1dnZkdnQ2aXRfYjhXd3dRMTdIQ1hQQ19PRng3cVlMZHB4RGJ6d3VyR2I5RG5KR01aY0czblJfSkZLcTl5NWhzcEhnVEdfZ3RDcFUwQ3B4MFd6VkROZWxWM3JaVDh0V3BVcjZORVNVZExaaFNjZUVGcUF4WWxheUtoekdkcV9DUm4?oc=5", "source_name": "Market source", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics expands Phase III trial to 25 sites", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxQenRVQ1BVcnFXUmZvblowMUdFOWtlLTF4Y2FFNlBZRTFvSTBDdWIyQTlXYmtzVVBBcTdkVFIxTGpHc0VxVXpGVnMtNC1NNmo5Z1NLX3ZBMnk2RmRGMW5tT3IySS1yZEplSnM4TDF3d2pnWUtqanBobTlRZVp2UTZDai1OYWhVOXg3SWdHUC1RTldVbVZxa3NTZWhuYUJSSjQ4ZmVXUmFZZG4tTkN1cEZBQmF3VQ?oc=5", "source_name": "Investing.com", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol plans 7 more U.S. sites for heart-drug trial at 75% enrollment", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPeXdpX3hRd2pKVndmTEZzTjdtT2R0dTJqU0FIZVh0cTFGM3dPQ1k5S1VCcTFiT3F0aFdUWEtaeW5wS294RXZiNWJ4VUhyYks2RVdsRnZnY0h3aVlnQThjYUs5QVNDcUZJSW1EeW1JWHFxOEYyOTNVYnVqVWNnMS1xTWZuT0JIS3pxS0hwOHJuYkJzblZUNXBvWmd2Tjd1U1FtTVZONTBjVFJoaHZ4bm9jY293UjI3b0JmRzZVdTZzWQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fixing Heart Disease Tied to Sudden Death in Young People | David Elsley - Cardiol Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNTndjY05FVlpnY19BX3Z4bHpNS3RfQ2RGbmNMRDdqOEJtUHp5MndhTFJsQ0lOeHZXUnJ6Qzktb2x0dnpBbWxzNUpJelJwM1c3aWh3dDgwY3k0STYyTG9zMGZTYjhUZEJqMmdIOTZVa3dUMWF1VWlLeXRadkZ3M2gxb0FLVjEzSFZBRFdPdFRheFJXS3h6NHpSYnJpSEsyMXRQOHBBbGFjelhwNEtwUFdiV0dhWnlCUQ?oc=5", "source_name": "thedeepdive.ca", "published_at": "2026-04-19T07:00:00+00:00", "published_display": "19 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics to Highlight MAVERIC Phase III Trial and Recently Published ARCHER Results in Live Interview with Barchart", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxOb2lSay1nWVpGUDM5S1RNV1JUc09oLWJ1azV4T2RIeFZMSktKaDJYMlVKT0FjTVhqZk1lRnJaS05qMmJQT0JjUWd5ME1VZ01TMDZKeG1hS09tZEdCQktkT1FOc2QydFpaaDhoV0NweGpzMUQ1WjRqS3JYTlBqa3J0MWExWTRsM1hlZkZwdDJ0eDdvQ253Sm82dmFRUEVsbERxc2g2QTMwSENqUFdHMFZBYnR2ZUhkWjhjX01JR01vS01SMGJqbjR5bjNNYzVvMVZuNGlWdDBNeXFmbmhSckdLQ1VDd1hMZ3BGZFdZVUhhck5xa1NJUVRIX0tmU25vNXNY?oc=5", "source_name": "TMX Newsfile", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOeVBmeXFtSGlOWE9IMTl6c2o1ZTVBcC15Y0VoUjRCMW54ZnNHa0ZaU0lQWEZfcGJyTkZnS3dXVzExdjlvcXhIWHdFWndMZERLTVBBNXp3TEFPbGxVVVk5SDBGVE5RR2xfa0dmTnFuZjlGZ1pqMWlkNUp0V3RmcjZpV1lSdUZXcmJmQzZEbWtiZFRuMHdWdU1jT2FhNXNZWVpDOTUwNWJmOWFfOE1MZFQ5STlCcm9YX0xwOUE?oc=5", "source_name": "Investing News Network", "published_at": "2026-01-26T17:29:20+00:00", "published_display": "26 Jan 2026 17:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwJBVV95cUxOMm5RN3VLTXNTcWV3LU1DcnhFMXVBZFQzdVNqZWhpSG92ckdxOWNrSDdXcHBYVTlpcGNIRWNNSWhwVUs2OHBzTTg3Y2dLNHVJQldkRUpaY2lKY1dfZWY1TzlUY20wR2Q5SmNEZm01N2cyS1Z4bnh2MTNhdlM5TXRkSnJfckNIVzJnTGZFQmwyajVpZ1M2OHpZcTlRbXNqemI5V3hTZExRRlRSS1pyaUNnOWtza1lScUFJbUZ6cDctaW93REdWUTFlY3otb1JJa2JCU2k2MFR5QVNLUEVYclFQY3h6Si1oU0FwT3A4Y3JhZFhOdmF2MFBrTTJUMHhJbHhlWE5WRU9aMGNVY1BpOEdJN2wzVQ?oc=5", "source_name": "TMX Newsfile", "published_at": "2026-01-23T08:00:00+00:00", "published_display": "23 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Expect Breakeven For Cardiol Therapeutics Inc. (TSE:CRDL) Before Long", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOTW1hcHZDMzN4dEU1TmNEcFJ0cnZsMVo3eUJONmZxMWoyM1BsWXlzUEdDRFQ1RjktMy0xRVdXcWJKWXJmSzE3RmgtYnhSaGhNYVRkWC10QVZLOU9WMVo5ekxHZUlBUkIydlRwSndKOVZVbUhTSnI0RzMxR1pucldmX1BvbnlHdjV0NXVTYnJnU0thdGNHMUJZ?oc=5", "source_name": "Market source", "published_at": "2026-01-12T08:00:00+00:00", "published_display": "12 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQbjlHREVLaEdnQlFUanZuV0pSem5IamFoeml6OGNtVEZsbnFLVDN0N2piRVNBemJ5eGlEWGt1aUFDdkVUZ1VBakhmRGU2ZTIwQWlTOXVydEdlREpnaVpjQjZ6VjBwTzJNczR3Z0x5VUhaQmR1enJrdVVQazZYQ1MxVm55TTZDX2R1TjlrNXdIRGtKRXc2SEFOZWNLaks5TjNkb3B5c3NaU09NanpzSWNxYjZUX2plRG9wQ0c2TEUzMUs0M00?oc=5", "source_name": "Investing News Network", "published_at": "2025-11-13T08:00:00+00:00", "published_display": "13 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into Q3 2027", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQd2JTakl5dzA3czNfYVctbUJUTDMwMzBDY0c2eVc3T1NMczBfaFd1eFVDMEc2R21CdENmSEZPdGlMdFhreTBOM3pEQktCNW5hTko5bzZZQXNqdTNzZzhwMFF6NEY2dFlXakJSYmhkVld4TkQ4SzN5U0U2dDRIRm40VlVweVlZWnpRUFE2eGRlMzJ5SGo5QlVyYkw4QnE4MWo5bm1oWTU0bmVpcnZWdXhkbG1pNFYzLWhfZ3VwekRBVmd6djJhSUdDRWQ1OWhVMFVVbkE?oc=5", "source_name": "TMX Newsfile", "published_at": "2025-10-21T07:00:00+00:00", "published_display": "21 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Medical Breakthrough the Market Overlooked | David Elsley \u2013 Cardiol Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPRkdrdE42WENpUEV2S0ctYWMzbGVnTkFRV2FiWGFYOC1McmJ4Z1JYeTROTW5Mb1E3ZUUtaTloMXEzX2xaNHExVTlOdWpLelpKZjBIWFRBSUNDYlZwRV9RSEEyVVRzRWNOcnpZREFFM3dpNEpMSTJaYktwZW9hSS12YlFOaGd6UDFJcWRsVHRFNVFhbnE2NkdWanltNWpXSV9hR1JZOA?oc=5", "source_name": "thedeepdive.ca", "published_at": "2025-08-18T07:00:00+00:00", "published_display": "18 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQZnljV0FtV1BPUThTNlJ5dEw3RDdPQWl1bE5WV3RjRG9wR1JZWEprdEFSTlc1RVg4S3huZE9ybFVaRXhJNFlXZWwxQTkxcTdKanpUbzhiU05OM1A0THU0YXRZbkRnWmc1cUlmREtYYjhWckJONnZyc0VSV01rTldUaUNmMlF3ckNWVFdtRkhsNjVQQm1TaDhtWlFoOW5jcWVPanRoYng4ZjkySmgybTRiMGpLcGZzblI1MWtIQUxrYjlPUU1jVmdQcVBEb19aSmxEcXAtNjd0RDY?oc=5", "source_name": "Investing News Network", "published_at": "2025-08-06T07:00:00+00:00", "published_display": "06 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Announces Year-End 2024 Update on Operations", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOTW9mb2Q4R09sQXFJN3lReDJyVnNqdXd4dVMtSDltQU8zN1lGdFN4RWc1YW5QZWJWSlhjSDhkYWhvVFRWMlRWcHlaRFI4Yl9tNzJ6aWFRU3pfU3BoWFp4TWJtSU9RYkd0alhILTlCSHY2b0I4cnJxeXdUeHNnUlNsYnBWZEVVVFMzdU5aRjlNMkRzZDlMRDQw?oc=5", "source_name": "Investing News Network", "published_at": "2025-04-01T07:00:00+00:00", "published_display": "01 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Announces Pricing of Public Offering of Common Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQR0QtX0JnTW15eWxBMDJIVS1mMmxfcDVMTi1CZHFOYkxHc3RGWG40RWtKZEpGeUZjQVhzTTJuaERjUndVazhiZHhBeXF6dUZBWFNBc2R2NTNVOTJIVkRqS1RVaWMwZndHc0czM01IVG85Q1RhbGtwYWtLLVk3Vzl0dk84SFlReXUzTURheG4xcU1aMXlHeFcwbWNJdmtUY0czUUI4?oc=5", "source_name": "Investing News Network", "published_at": "2024-10-09T07:00:00+00:00", "published_display": "09 Oct 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Common Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQUF9ZakZQY0tSTko1MlNqY0FZX2llcmh6T21TeTFFYmNab3EzZTRZSm1MNFkxYUdwMmZGaHNsUElzVkNqSWRZM3JzdDYzTFZlaUtiUmtBVnRSeVhDMWpzeWhLWk9DYXprVVJnaHVrMElHcnFPSEtTMUlxWVdCRHM1SzJNWlowOFhIWjk4czE1VHFrSlBWOGRBMFhROFY3Wkc4Qm1qZndpcDdGa3JWcEREMjFCQzRDVktobjZxeEJ4SnBIYk9Ja3lFc1Q0OGhSZw?oc=5", "source_name": "Investing News Network", "published_at": "2024-10-08T07:00:00+00:00", "published_display": "08 Oct 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Regains Compliance with all Applicable Listing Standards of The Nasdaq Capital Market", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxNRFNuOEFrR29OUkpXbWhUNW5XVm9XVkVRQUc4Qjh1SFY4LXRiSWZVbm5uS0lTUDBrVUFRdFBSSjVSTlZuVElPckhuNFdrV3R6SWVMQllseTh4QWRWSjUwaFpicjhNMktOUG9kSmpuY3IzVDdnM0VvblI3Vjc1b3Bfa3JXd3V4Vnh5RDRsV2xJZjB3V0Q0RjhGdWJBUXVYQjQ3M3VrVVJ0Z1licG1GdUtzSkxoRVUwR3d1aVF6YWdYQVhPR3hTclQyWTdIVGlINTRtaUx3Y1NQLXVtbXEyX3VV?oc=5", "source_name": "Investing News Network", "published_at": "2024-01-24T08:00:00+00:00", "published_display": "24 Jan 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Announces At-The-Market Equity Offering Program", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNYVdHYmc4VGd0bjRRVjcyN2lrS3NOaG1tRFUyZXN0d2FJSU16QmFEVWFXQ1VyTWgyRFNpaXJRNHE4ekpJWmtRTEZORVdOWlE5TjZRNjlKM0pVSEdGY0RQYXB0X3pFMTdheGRXRHNCUkEzV1l3S1J3SWVYamgtSWVRWUFCSkpHZ0hzU290UGtkVDFkYWF3NHBzdEVqbEdQNjBROFB2X2d0Y29jRzVhcGc0?oc=5", "source_name": "TMX Newsfile", "published_at": "2022-06-09T07:00:00+00:00", "published_display": "09 Jun 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics to Commence Trading on NASDAQ Under the Symbol \"CRDL\"", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNSE0tMi15OTgyR3Q1cjJzaU43b0psbUtxLXE5aHo1X1doWW9QU01tb0N6NWtKSUF0NWFhd1J5MnJ4QjZZdlE0S0JtQU1iYk9ET3BzR3JCd1pHY3c3VV92b1c2UWdiY005MUhsdHJmaWhfTHpnVHpBSW8tM1d2YkJYUDV3QXlqOFB3TnpMeWxZV0V4RHhP?oc=5", "source_name": "Market source", "published_at": "2021-08-09T07:00:00+00:00", "published_display": "09 Aug 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Cardiol Therapeutics Inc (CRDL) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE5pUWNuWENHNTZSbVdRNGhLS2JGcXdwbm5GQ2JobUFnNElDRDMyTEo4VGJmYkRzREcwQmd0ZGFpTDFsTTdKX1pJSF9TWFpOZEs4UDhHLVI0blpTdElOc19uQ3lZUUhBSzhOdVRBc0czSkQ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-19T03:20:32+00:00", "published_display": "19 Jun 2026 03:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Inc (CRDL) Institutional Confidence", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTFBVTnNDZ283ajdVMDczV1Y1N0syVnNwSTZHYy1MWGJsRkotS01JMjZWZUplOHdLWXlFeDJNUXlkUzQ2MkNNZEttbHNtNk0yM1l6Q25hTEVoc1lmSW1FRm1jNEpCWFhGRzdrVExvZjdjVGY?oc=5", "source_name": "TradingKey", "published_at": "2026-06-19T02:43:36+00:00", "published_display": "19 Jun 2026 02:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Inc (CRDL) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE9SeUNWb3JHTWZ3T3ctemN4LUFBdnh2RUpnM1FyaGN5YTVBNTcxSUxpTDNFRlF2dVA3cjBERmxveV9acDBtSWVsUnVKLW1vczVTQ2l2UWZGbUViYWxvcVZFYlNidEFzU21YeW9XbWltYlRzWXlNVXZR?oc=5", "source_name": "TradingKey", "published_at": "2026-06-19T02:41:30+00:00", "published_display": "19 Jun 2026 02:41", "sentiment": "negative", "sentiment_pct": 5, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Inc (CRDL) Financial Health: Profitability & Balance Sheet Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTFB4QlEwRzF6WlJua0VEdW9RYWtabXRUNEZVZWNFenRqYmVLdC1oQk5xNG8tMlJIMEtnMTM5WUY1V0NtUkotR05Rclo4M3ljd2VkTDBmZDRQaTQxQ211N0lrbTc0SEpZMGVkbXozQzBDbzRsMXYtb24wa1lR?oc=5", "source_name": "TradingKey", "published_at": "2026-06-19T02:13:47+00:00", "published_display": "19 Jun 2026 02:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CRDL News | CARDIOL THERAPEUTICS INC-A (NASDAQ:CRDL)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTFBQbzZOVkRLVk1yUUlFLTgtYkFJYUp0eng4bDc5M29fMDhSUjU0bWNMZk9vZGEtcGQxVE1neThHQjVsVWI3N2wzRjFBWkQtdlYza3hGeXlEb09YSzA?oc=5", "source_name": "ChartMill", "published_at": "2026-06-19T00:00:01+00:00", "published_display": "19 Jun 2026 00:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Inc (CRDL) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTE1CUkwyN2ljQ29LSVRfV0Q5TnozcjhIbDdCS1pHVkpxY19Wbmp4NXlDRzltZ3MwM3ZYOERtM3Y4Ymp6S1ZSQnJiZjd4WjFmZHR0WnZxbkVLYnB0UERuSFZhQkRXbEUycnFXU05tUUotSQ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T23:39:30+00:00", "published_display": "18 Jun 2026 23:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Inc (CRDL) Valuation: PE, PB & Fair Value Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE1RMDNfVDJxMjZsek96NFhyR0NGb1Z0bklxbXhzVTZqOTJIbW94Q1N3bkJDcWdNbGFPVi1PVXExRkY1NE5SWHAtYzVLR1dKQ25oRkhQOWVJMHJYZ0NSVVNFWk43a2J3QjRuVDdxcjZHQ3U2NENPXzRfVjVTWQ?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T23:34:21+00:00", "published_display": "18 Jun 2026 23:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Inc (CRDL) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE5Mc1lWTlc0SlczaUpoTjRyM0dQYVBjNWpaNWtMSU51Z3FxWmhxd0xjZmZGanhDM05pS1BRQ05QSE53M05aYTI3anc4Zl85Wk16QlpDWXZZdEdBeF9qblV2UjlZXzNZLVpVRlZZZmZYWFA?oc=5", "source_name": "TradingKey", "published_at": "2026-06-17T21:31:22+00:00", "published_display": "17 Jun 2026 21:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Inc (CRDL) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE9jUUk1dU0tczIwaC1DT2FjVHhHemNYNWZDU3RwR0FFR0VDd3RoemN4RDNGdFBPMVZRV252V0pDYlV1bjQtaWNYNk1DcTBGdUVxcmZ0cjZLTlVqZ3hBUk1MUzllU1dYVXlBMzRBRmstQ1NYZzRxcVdKUA?oc=5", "source_name": "TradingKey", "published_at": "2026-06-17T12:13:09+00:00", "published_display": "17 Jun 2026 12:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Inc (CRDL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTFBoM1dXeGxCbW5mNm9meXo5aEhKaUN2ZXBwZzhaVkVwaWhTU1E3NHhOSFJTNzBROGxFbDNSNUUwTjlSckRLWG1HVWdnQ291NUZxd3MtSnY5YWdscjcxRm4zX19LNXlFX3drRlJNZjNR?oc=5", "source_name": "TradingKey", "published_at": "2026-06-17T11:22:24+00:00", "published_display": "17 Jun 2026 11:22", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Cardiol Therapeutics (TSE:CRDL) In A Good Position To Invest In Growth?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why We're Watching Cardiol Therapeutics' (TSE:CRDL) Cash Burn Situation", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQcFVTZHF1Ty1SYkxkVGE0dm5qM0Z1dnZkdnQ2aXRfYjhXd3dRMTdIQ1hQQ19PRng3cVlMZHB4RGJ6d3VyR2I5RG5KR01aY0czblJfSkZLcTl5NWhzcEhnVEdfZ3RDcFUwQ3B4MFd6VkROZWxWM3JaVDh0V3BVcjZORVNVZExaaFNjZUVGcUF4WWxheUtoekdkcV9DUm4?oc=5", "source_name": "Market source", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics expands Phase III trial to 25 sites", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxQenRVQ1BVcnFXUmZvblowMUdFOWtlLTF4Y2FFNlBZRTFvSTBDdWIyQTlXYmtzVVBBcTdkVFIxTGpHc0VxVXpGVnMtNC1NNmo5Z1NLX3ZBMnk2RmRGMW5tT3IySS1yZEplSnM4TDF3d2pnWUtqanBobTlRZVp2UTZDai1OYWhVOXg3SWdHUC1RTldVbVZxa3NTZWhuYUJSSjQ4ZmVXUmFZZG4tTkN1cEZBQmF3VQ?oc=5", "source_name": "Investing.com", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol plans 7 more U.S. sites for heart-drug trial at 75% enrollment", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPeXdpX3hRd2pKVndmTEZzTjdtT2R0dTJqU0FIZVh0cTFGM3dPQ1k5S1VCcTFiT3F0aFdUWEtaeW5wS294RXZiNWJ4VUhyYks2RVdsRnZnY0h3aVlnQThjYUs5QVNDcUZJSW1EeW1JWHFxOEYyOTNVYnVqVWNnMS1xTWZuT0JIS3pxS0hwOHJuYkJzblZUNXBvWmd2Tjd1U1FtTVZONTBjVFJoaHZ4bm9jY293UjI3b0JmRzZVdTZzWQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fixing Heart Disease Tied to Sudden Death in Young People | David Elsley - Cardiol Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNTndjY05FVlpnY19BX3Z4bHpNS3RfQ2RGbmNMRDdqOEJtUHp5MndhTFJsQ0lOeHZXUnJ6Qzktb2x0dnpBbWxzNUpJelJwM1c3aWh3dDgwY3k0STYyTG9zMGZTYjhUZEJqMmdIOTZVa3dUMWF1VWlLeXRadkZ3M2gxb0FLVjEzSFZBRFdPdFRheFJXS3h6NHpSYnJpSEsyMXRQOHBBbGFjelhwNEtwUFdiV0dhWnlCUQ?oc=5", "source_name": "thedeepdive.ca", "published_at": "2026-04-19T07:00:00+00:00", "published_display": "19 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics to Highlight MAVERIC Phase III Trial and Recently Published ARCHER Results in Live Interview with Barchart", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxOb2lSay1nWVpGUDM5S1RNV1JUc09oLWJ1azV4T2RIeFZMSktKaDJYMlVKT0FjTVhqZk1lRnJaS05qMmJQT0JjUWd5ME1VZ01TMDZKeG1hS09tZEdCQktkT1FOc2QydFpaaDhoV0NweGpzMUQ1WjRqS3JYTlBqa3J0MWExWTRsM1hlZkZwdDJ0eDdvQ253Sm82dmFRUEVsbERxc2g2QTMwSENqUFdHMFZBYnR2ZUhkWjhjX01JR01vS01SMGJqbjR5bjNNYzVvMVZuNGlWdDBNeXFmbmhSckdLQ1VDd1hMZ3BGZFdZVUhhck5xa1NJUVRIX0tmU25vNXNY?oc=5", "source_name": "TMX Newsfile", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOeVBmeXFtSGlOWE9IMTl6c2o1ZTVBcC15Y0VoUjRCMW54ZnNHa0ZaU0lQWEZfcGJyTkZnS3dXVzExdjlvcXhIWHdFWndMZERLTVBBNXp3TEFPbGxVVVk5SDBGVE5RR2xfa0dmTnFuZjlGZ1pqMWlkNUp0V3RmcjZpV1lSdUZXcmJmQzZEbWtiZFRuMHdWdU1jT2FhNXNZWVpDOTUwNWJmOWFfOE1MZFQ5STlCcm9YX0xwOUE?oc=5", "source_name": "Investing News Network", "published_at": "2026-01-26T17:29:20+00:00", "published_display": "26 Jan 2026 17:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwJBVV95cUxOMm5RN3VLTXNTcWV3LU1DcnhFMXVBZFQzdVNqZWhpSG92ckdxOWNrSDdXcHBYVTlpcGNIRWNNSWhwVUs2OHBzTTg3Y2dLNHVJQldkRUpaY2lKY1dfZWY1TzlUY20wR2Q5SmNEZm01N2cyS1Z4bnh2MTNhdlM5TXRkSnJfckNIVzJnTGZFQmwyajVpZ1M2OHpZcTlRbXNqemI5V3hTZExRRlRSS1pyaUNnOWtza1lScUFJbUZ6cDctaW93REdWUTFlY3otb1JJa2JCU2k2MFR5QVNLUEVYclFQY3h6Si1oU0FwT3A4Y3JhZFhOdmF2MFBrTTJUMHhJbHhlWE5WRU9aMGNVY1BpOEdJN2wzVQ?oc=5", "source_name": "TMX Newsfile", "published_at": "2026-01-23T08:00:00+00:00", "published_display": "23 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Expect Breakeven For Cardiol Therapeutics Inc. (TSE:CRDL) Before Long", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOTW1hcHZDMzN4dEU1TmNEcFJ0cnZsMVo3eUJONmZxMWoyM1BsWXlzUEdDRFQ1RjktMy0xRVdXcWJKWXJmSzE3RmgtYnhSaGhNYVRkWC10QVZLOU9WMVo5ekxHZUlBUkIydlRwSndKOVZVbUhTSnI0RzMxR1pucldmX1BvbnlHdjV0NXVTYnJnU0thdGNHMUJZ?oc=5", "source_name": "Market source", "published_at": "2026-01-12T08:00:00+00:00", "published_display": "12 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQbjlHREVLaEdnQlFUanZuV0pSem5IamFoeml6OGNtVEZsbnFLVDN0N2piRVNBemJ5eGlEWGt1aUFDdkVUZ1VBakhmRGU2ZTIwQWlTOXVydEdlREpnaVpjQjZ6VjBwTzJNczR3Z0x5VUhaQmR1enJrdVVQazZYQ1MxVm55TTZDX2R1TjlrNXdIRGtKRXc2SEFOZWNLaks5TjNkb3B5c3NaU09NanpzSWNxYjZUX2plRG9wQ0c2TEUzMUs0M00?oc=5", "source_name": "Investing News Network", "published_at": "2025-11-13T08:00:00+00:00", "published_display": "13 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into Q3 2027", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQd2JTakl5dzA3czNfYVctbUJUTDMwMzBDY0c2eVc3T1NMczBfaFd1eFVDMEc2R21CdENmSEZPdGlMdFhreTBOM3pEQktCNW5hTko5bzZZQXNqdTNzZzhwMFF6NEY2dFlXakJSYmhkVld4TkQ4SzN5U0U2dDRIRm40VlVweVlZWnpRUFE2eGRlMzJ5SGo5QlVyYkw4QnE4MWo5bm1oWTU0bmVpcnZWdXhkbG1pNFYzLWhfZ3VwekRBVmd6djJhSUdDRWQ1OWhVMFVVbkE?oc=5", "source_name": "TMX Newsfile", "published_at": "2025-10-21T07:00:00+00:00", "published_display": "21 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Medical Breakthrough the Market Overlooked | David Elsley \u2013 Cardiol Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPRkdrdE42WENpUEV2S0ctYWMzbGVnTkFRV2FiWGFYOC1McmJ4Z1JYeTROTW5Mb1E3ZUUtaTloMXEzX2xaNHExVTlOdWpLelpKZjBIWFRBSUNDYlZwRV9RSEEyVVRzRWNOcnpZREFFM3dpNEpMSTJaYktwZW9hSS12YlFOaGd6UDFJcWRsVHRFNVFhbnE2NkdWanltNWpXSV9hR1JZOA?oc=5", "source_name": "thedeepdive.ca", "published_at": "2025-08-18T07:00:00+00:00", "published_display": "18 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQZnljV0FtV1BPUThTNlJ5dEw3RDdPQWl1bE5WV3RjRG9wR1JZWEprdEFSTlc1RVg4S3huZE9ybFVaRXhJNFlXZWwxQTkxcTdKanpUbzhiU05OM1A0THU0YXRZbkRnWmc1cUlmREtYYjhWckJONnZyc0VSV01rTldUaUNmMlF3ckNWVFdtRkhsNjVQQm1TaDhtWlFoOW5jcWVPanRoYng4ZjkySmgybTRiMGpLcGZzblI1MWtIQUxrYjlPUU1jVmdQcVBEb19aSmxEcXAtNjd0RDY?oc=5", "source_name": "Investing News Network", "published_at": "2025-08-06T07:00:00+00:00", "published_display": "06 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Announces Year-End 2024 Update on Operations", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOTW9mb2Q4R09sQXFJN3lReDJyVnNqdXd4dVMtSDltQU8zN1lGdFN4RWc1YW5QZWJWSlhjSDhkYWhvVFRWMlRWcHlaRFI4Yl9tNzJ6aWFRU3pfU3BoWFp4TWJtSU9RYkd0alhILTlCSHY2b0I4cnJxeXdUeHNnUlNsYnBWZEVVVFMzdU5aRjlNMkRzZDlMRDQw?oc=5", "source_name": "Investing News Network", "published_at": "2025-04-01T07:00:00+00:00", "published_display": "01 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Announces Pricing of Public Offering of Common Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQR0QtX0JnTW15eWxBMDJIVS1mMmxfcDVMTi1CZHFOYkxHc3RGWG40RWtKZEpGeUZjQVhzTTJuaERjUndVazhiZHhBeXF6dUZBWFNBc2R2NTNVOTJIVkRqS1RVaWMwZndHc0czM01IVG85Q1RhbGtwYWtLLVk3Vzl0dk84SFlReXUzTURheG4xcU1aMXlHeFcwbWNJdmtUY0czUUI4?oc=5", "source_name": "Investing News Network", "published_at": "2024-10-09T07:00:00+00:00", "published_display": "09 Oct 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Common Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQUF9ZakZQY0tSTko1MlNqY0FZX2llcmh6T21TeTFFYmNab3EzZTRZSm1MNFkxYUdwMmZGaHNsUElzVkNqSWRZM3JzdDYzTFZlaUtiUmtBVnRSeVhDMWpzeWhLWk9DYXprVVJnaHVrMElHcnFPSEtTMUlxWVdCRHM1SzJNWlowOFhIWjk4czE1VHFrSlBWOGRBMFhROFY3Wkc4Qm1qZndpcDdGa3JWcEREMjFCQzRDVktobjZxeEJ4SnBIYk9Ja3lFc1Q0OGhSZw?oc=5", "source_name": "Investing News Network", "published_at": "2024-10-08T07:00:00+00:00", "published_display": "08 Oct 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Regains Compliance with all Applicable Listing Standards of The Nasdaq Capital Market", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxNRFNuOEFrR29OUkpXbWhUNW5XVm9XVkVRQUc4Qjh1SFY4LXRiSWZVbm5uS0lTUDBrVUFRdFBSSjVSTlZuVElPckhuNFdrV3R6SWVMQllseTh4QWRWSjUwaFpicjhNMktOUG9kSmpuY3IzVDdnM0VvblI3Vjc1b3Bfa3JXd3V4Vnh5RDRsV2xJZjB3V0Q0RjhGdWJBUXVYQjQ3M3VrVVJ0Z1licG1GdUtzSkxoRVUwR3d1aVF6YWdYQVhPR3hTclQyWTdIVGlINTRtaUx3Y1NQLXVtbXEyX3VV?oc=5", "source_name": "Investing News Network", "published_at": "2024-01-24T08:00:00+00:00", "published_display": "24 Jan 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics Announces At-The-Market Equity Offering Program", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNYVdHYmc4VGd0bjRRVjcyN2lrS3NOaG1tRFUyZXN0d2FJSU16QmFEVWFXQ1VyTWgyRFNpaXJRNHE4ekpJWmtRTEZORVdOWlE5TjZRNjlKM0pVSEdGY0RQYXB0X3pFMTdheGRXRHNCUkEzV1l3S1J3SWVYamgtSWVRWUFCSkpHZ0hzU290UGtkVDFkYWF3NHBzdEVqbEdQNjBROFB2X2d0Y29jRzVhcGc0?oc=5", "source_name": "TMX Newsfile", "published_at": "2022-06-09T07:00:00+00:00", "published_display": "09 Jun 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardiol Therapeutics to Commence Trading on NASDAQ Under the Symbol \"CRDL\"", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNSE0tMi15OTgyR3Q1cjJzaU43b0psbUtxLXE5aHo1X1doWW9QU01tb0N6NWtKSUF0NWFhd1J5MnJ4QjZZdlE0S0JtQU1iYk9ET3BzR3JCd1pHY3c3VV92b1c2UWdiY005MUhsdHJmaWhfTHpnVHpBSW8tM1d2YkJYUDV3QXlqOFB3TnpMeWxZV0V4RHhP?oc=5", "source_name": "Market source", "published_at": "2021-08-09T07:00:00+00:00", "published_display": "09 Aug 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 67, "total_relevant": 29, "sentiment_summary": {"positive": 4, "negative": 1, "neutral": 24, "score": 50, "total": 29, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 85, "events": [{"event": "general", "label": "Market update", "weight": 11.55, "count": 21}, {"event": "earnings", "label": "Earnings", "weight": 2.2, "count": 4}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}], "positive_events": 4, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 1.5, "latest_week": "2026-06-19", "one_week_move": 3.1, "four_week_move": -17.3, "twelve_week_move": -12.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.431796, "market_dynamics_buy_signal": false, "relative_strength": -15.561516, "fair_value_gap": -18.0, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 47.0588, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+3.1% over one week, -17.3% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 60, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingKey", "count": 9}, {"label": "Investing News Network", "count": 7}, {"label": "TMX Newsfile", "count": 4}, {"label": "Market source", "count": 3}, {"label": "thedeepdive.ca", "count": 2}, {"label": "ChartMill", "count": 1}, {"label": "simplywall.st", "count": 1}, {"label": "Investing.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 29}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 21}, {"label": "Earnings", "count": 4}, {"label": "Balance sheet", "count": 2}, {"label": "Deals and strategy", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "85/100 classification confidence."}, {"label": "Company focus", "value": "29", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+3.1% over one week, -17.3% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Cardiol Therapeutics Inc (CRDL) Technical Analysis: Support, Resistance, Indicators & Moving Averages"}], "updated_at": "2026-06-23T01:07:10.702908+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}